Multiple Assemblies exist for SMTL entry 5dt2
Crystal structure of Dot1L in complex with inhibitor CPD11 [N4-methyl-N2-(2-methyl-1-(2-phenoxyphenyl)-1H-indol-6-yl)pyrimidine-2,4-diamine]; X-RAY DIFFRACTION 2.30 Å

	SMTL ID 5dt2.1 Ligands N~4~-methyl-N~2~-[2-methyl-1-(2-phenoxyphenyl)-1H-indol-6-yl]pyrimidine-2,4-diamine; SULFATE ION Polypeptides Histone-lysine N-methyltransferase, H3 lysine-79 specific Oligo-state monomer
	SMTL ID 5dt2.2 Ligands N~4~-methyl-N~2~-[2-methyl-1-(2-phenoxyphenyl)-1H-indol-6-yl]pyrimidine-2,4-diamine; SULFATE ION Polypeptides Histone-lysine N-methyltransferase, H3 lysine-79 specific Oligo-state monomer